TRT Dosing Frequency: Weekly vs Twice-Weekly vs Daily Microdose

TRT dosing frequency is about a single tradeoff: how often you inject versus how stable your hormone levels stay. As a rule, more frequent injections smooth out the peaks and troughs of testosterone and estradiol, which some people find reduces side effects, while less frequent injections are simpler but swing more. Weekly, twice-weekly, and daily microdosing each sit at a different point on that curve, and the right one is individual and set by your clinician based on your labs and how you feel, not by a rule from an article.

First, the Non-Negotiables

This article covers conceptual tradeoffs only. It does not tell you what dose to take or how often to inject, because that is a clinical decision that belongs to a licensed provider who has your labs and history. Testosterone is a Schedule III controlled substance in the US and is prescription-only.

For context, standard total doses reported in the TRT literature commonly fall in the range of 100 to 200 mg per week, titrated to labs, but that is a typical clinician-managed range, not a recommendation, and the same weekly amount can be delivered on very different schedules. If you are new to the fundamentals, TRT basics covers diagnosis, delivery methods, and monitoring first.

Why Frequency Matters: Peaks, Troughs, and Half-Life

Injectable testosterone esters like cypionate and enanthate are long-acting: after an injection, blood levels rise to a peak, then decline over days as the ester is metabolized. The half-life (the time for levels to fall by half) is roughly 7 to 8 days for cypionate and 4 to 5 days for enanthate, though the practical difference between them is small (covered in testosterone cypionate vs enanthate).

The key idea: if you inject a larger amount less often, you get a higher peak and a lower trough before the next dose. If you split the same total into smaller, more frequent injections, the peaks come down and the troughs come up, so levels stay in a narrower band. This is the same pharmacokinetic logic that drives the appetite and side-effect rhythm GLP-1 users feel across their dosing week, explained in the GLP-1 dose week and PK curve.

Why does the band matter? Two reasons. First, some people feel symptoms at the trough, such as fatigue or mood dips in the day or two before the next dose. Second, testosterone aromatizes (converts) to estradiol partly in relation to peak levels, so higher peaks can mean larger estradiol spikes, which for some people drive water retention or mood changes.

The Three Common Approaches

Below are the three frequencies most often discussed in clinical practice, framed as concepts rather than protocols. Doses are deliberately not specified; your clinician sets those.

Once weekly

The simplest schedule: one injection per week. It is easy to remember and minimizes needle days. The tradeoff is the largest peak-to-trough swing, and some patients notice a dip in the day or two before their next dose.

Twice weekly

The same weekly amount split into two injections, typically a few days apart. This is the most common clinical approach today. Splitting the dose tends to reduce peak-to-trough swings and can lower estradiol peaks from aromatization, which is why many endocrinologists and TRT clinicians favor it. The cost is doubling the number of injections.

Daily microdosing

A small amount injected every day or nearly every day. This produces the steadiest levels, closest to a physiologic pattern, with minimal peaks and troughs, though it still does not perfectly mimic the body's natural morning surge. Some clinicians reserve it for patients who are particularly sensitive to estradiol swings. The tradeoff is adherence: daily injections are the most demanding to maintain and the easiest to skip.

Frequency Tradeoffs at a Glance

This table summarizes the conceptual tradeoffs. It is educational, not a recommendation, and it deliberately omits doses.

Schedule	Level stability	Peak/trough swing	Injection burden	Conceptual side-effect implication
Once weekly	Lower	Largest	Lowest (1 per week)	Possible trough symptoms; higher peaks may mean larger estradiol spikes
Twice weekly	Higher	Reduced	Moderate (2 per week)	Smoother levels; often lower estradiol peaks; common default
Daily microdose	Highest	Smallest	Highest (daily)	Steadiest levels; sometimes used for estradiol-sensitive patients; adherence is the challenge

The pattern is consistent: stability and injection burden move together. More steadiness costs more frequent injections. Where you land on that curve is a personal and clinical decision, not a one-size answer.

Route Is Part of the Picture, Too

Frequency is not the only variable. The same testosterone can be injected intramuscularly (the traditional route) or subcutaneously (smaller needles, often lower peaks). Some evidence suggests subcutaneous injection may produce lower estradiol conversion for some patients, though the data is mixed. Route, frequency, and ester are all levers your clinician can adjust based on your labs, which is why TRT is iterative rather than fixed at the first prescription.

Frequency Affects Monitoring

How often you inject also shapes what your bloodwork looks like and when it should be drawn. With less frequent dosing, the timing of a lab draw relative to your last injection matters more, because levels are swinging more. Your clinician will specify when to test (often at trough) so the numbers are interpretable. The full panel and rationale are in TRT bloodwork and labs, and because frequency can influence hematocrit response in some patients, hematocrit on TRT is worth reading alongside any frequency change. Broader side-effect management is covered in TRT side effects and how they're managed.

The Tracking Reality

Here is the practical wrinkle: the steadier schedules are also the easier ones to lose track of. A daily microdose is forty-plus injections a month to log, rotate sites for, and stay consistent on. That is where structured tracking earns its place.

Myo, an iOS app by PixelPort LLC, keeps a frequent schedule from slipping with injection reminders and a dose-and-site log, so an every-other-day or daily protocol runs as prescribed instead of from memory. Its medication-level visualizer shows how your levels ride across the dosing interval, which makes the peak-and-trough concept concrete for your specific schedule, and its injection-site map keeps rotation honest across all those extra needle days. Myo is a tracking and education tool only; it does not prescribe, source, or recommend doses or frequencies. Your clinician sets the protocol; Myo helps you follow it accurately and bring clean data to your follow-ups.

References

Endocrine Society: Testosterone Therapy Clinical Practice Guideline Guidance on TRT initiation, dosing principles, and monitoring; emphasizes individualized, lab-guided management. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy

FDA Testosterone Prescribing Information (2022) Label information for injectable testosterone esters, including pharmacokinetics and controlled-substance status. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216318s000lbl.pdf

TRT Nation: Testosterone Cypionate vs Enanthate and Injection Frequency (2026) Practitioner-oriented overview of ester half-lives and the rationale many clinicians cite for twice-weekly dosing. https://trtnation.com/testosterone-cypionate-vs-enanthate-which-is-more-effective-in-2026/

ASH Blood Advances: Drug-Induced Erythrocytosis (2025) Evidence on testosterone-associated hematocrit elevation, relevant to how dose and frequency are managed. https://ashpublications.org/bloodadvances/article/9/9/2108/535485/Diagnosis-management-and-outcomes-of-drug-induced